Reimbursement authority NICE published draft guidance today giving a green light to the use of Columvi (glofitamab) in ...
Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of ...
The survival rate of frozen eggs and embryos reaches more than 90% in good in vitro fertilization labs when a patient is ...
The use of hair straighteners and chemical relaxers may be associated with a higher incidence of pancreatic cancer, thyroid cancer, and non-Hodgkin’s lymphoma, according to a study.
New data from cohort 3 show EO2463 can be safely added to rituximab in first-line low-tumor-burden follicular lymphoma in need of treatment; All six patients responded positively ...
Preexisting autoimmune diseases are tied to shorter hospital stays and less toxicity risk in patients receiving chimeric ...
San Diego Padres chairman John Seidler announced the family is exploring "strategic options for the San Diego Padres, ...
Cancer treatment drug Pembroria, which has the same active ingredient as Keytruda but is cheaper, has been licensed for ...
As a four-time non-Hodgkin lymphoma survivor, Rowe, who first received her diagnosis in 2019 at the age of 20, found a sizable following online — including more than 79 million likes and 977,000 ...
ANTLER phase 1 data demonstrate efficacy and durability on par with autologous CAR-T cell therapy and safety allows for ...
Geertsen would spend four full seasons with the Colorado Avalanche’s AHL affiliates spanning the San Antonio Rampage and ...
Scientists have uncovered a new environmental culprit behind liver disease: tetrachloroethylene (PCE), a chemical used in dry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results